Brief: FDA Says Edwards Lifesciences Is Recalling Arterial Cannula
24/07/2025 19:26
July 24 (Reuters) - Edwards Lifesciences Corp EW.N: FDA: EDWARDS LIFESCIENCES IS RECALLING ARTERIAL CANNULA DUE TO RISK OF WIRE EXPOSURE FDA: IDENTIFIED ARTERIAL CANNULA RECALL AS THE MOST SERIOUS TYPE Further company coverage: EW.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edwards Lifesciences
See all newsFDA flags Edwards heart-valve delivery system issue after death, injury (updated)
FDA flags Edwards heart-valve delivery system issue after death, injury
Brief: FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed
Brief: Edwards Lifesciences Corporation - Maintains Confidence In Financial Guidance For 2026
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals